Cdex, Inc. (fka CDEX)

[d4diddy]

Crow,

"Perhaps a central purchasing point for a chain may use one to verify a new source, but I doubt it.""

Hosiptal pharmacies and drug stores are making it more and more convenient for people to call in their orders by phone. If the prescription requires a doctor's approval for refill it's a requirement to call in at least 24 hours in advance at my hospital.

When I called in my last prescription in advance I noticed the packaging was different from when I just walk in to the pharmacy and wait for my order to be filled.

Last time I asked the pharmacist and she told me that all call in orders come from central fill locations. Central fill locations fill thousands of prescriptions daily and are designed as a cost effective way to take the burden off local pharmacies.

A year ago I came across Spectral Analytical Devices at a trade show and learned of their patented spectral fingerprint identification technology that is remarkably similar to Valimed. McKesson has exclusive distribution rights to the validation system and have employed it in several central fill locations nation wide.

So you are correct, the central fill locations were the first targeted market for prescription validation by spectral fingerprinting.

I believe that Spectral Analytical Devices' patent has the market tighted up for that application. I had a chat with their VP of Technology (a cofouder of the company) and he said that they were aware of CDEX's niche market applications and were looking into the scope of their patent claims.

On the positive said I asked him what did he think about the niche market (hospitals) for the Valimed unit and his reply was "there are a lot of hospitals".